ACR Appropriateness Criteria®: Single Brain Metastasis

John H. Suh, Gregory M M Videtic, Amr M. Aref, Isabelle Germano, Brian J. Goldsmith, Joseph P. Imperato, Karen J. Marcus, Michael W. McDermott, Mark W. McDonald, Roy A. Patchell, H. Ian Robins, C. Leland Rogers, Aaron Wolfson, Franz J. Wippold, Laurie E. Gaspar

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Single brain metastasis represents a common neurologic complication of cancer. Given the number of treatment options that are available for patients with brain metastasis and the strong opinions that are associated with each option, appropriate treatment for these patients has become controversial. Prognostic factors such as recursive partitioning analysis and graded prognostic assessment can help guide treatment decisions. Surgery, whole brain radiation therapy (WBRT), stereotactic radiosurgery or combination of these treatments can be considered based on a number of factors. Despite Class I evidence suggestive of best therapy, the treatment recommendation is quite varied among physicians as demonstrated by the American College of Radiology's Appropriateness Panel on single brain metastasis. Given the potential concerns of the neurocognitive effects of WBRT, the use of SRS alone or SRS to a resection cavity has gained support. Since aggressive local therapy is beneficial for survival, local control and quality of life, the use of these various treatment modalities needs to be carefully investigated given the growing number of long-term survivors. Enrollment of patients onto clinical trials is important to advance our understanding of brain metastasis.

Original languageEnglish
Pages (from-to)162-174
Number of pages13
JournalCurrent Problems in Cancer
Volume34
Issue number3
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Brain
Therapeutics
Radiotherapy
Radiosurgery
Radiology
Nervous System
Survivors
Quality of Life
Clinical Trials
Physicians
Survival
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Suh, J. H., Videtic, G. M. M., Aref, A. M., Germano, I., Goldsmith, B. J., Imperato, J. P., ... Gaspar, L. E. (2010). ACR Appropriateness Criteria®: Single Brain Metastasis. Current Problems in Cancer, 34(3), 162-174. https://doi.org/10.1016/j.currproblcancer.2010.04.003

ACR Appropriateness Criteria® : Single Brain Metastasis. / Suh, John H.; Videtic, Gregory M M; Aref, Amr M.; Germano, Isabelle; Goldsmith, Brian J.; Imperato, Joseph P.; Marcus, Karen J.; McDermott, Michael W.; McDonald, Mark W.; Patchell, Roy A.; Robins, H. Ian; Rogers, C. Leland; Wolfson, Aaron; Wippold, Franz J.; Gaspar, Laurie E.

In: Current Problems in Cancer, Vol. 34, No. 3, 01.05.2010, p. 162-174.

Research output: Contribution to journalArticle

Suh, JH, Videtic, GMM, Aref, AM, Germano, I, Goldsmith, BJ, Imperato, JP, Marcus, KJ, McDermott, MW, McDonald, MW, Patchell, RA, Robins, HI, Rogers, CL, Wolfson, A, Wippold, FJ & Gaspar, LE 2010, 'ACR Appropriateness Criteria®: Single Brain Metastasis', Current Problems in Cancer, vol. 34, no. 3, pp. 162-174. https://doi.org/10.1016/j.currproblcancer.2010.04.003
Suh JH, Videtic GMM, Aref AM, Germano I, Goldsmith BJ, Imperato JP et al. ACR Appropriateness Criteria®: Single Brain Metastasis. Current Problems in Cancer. 2010 May 1;34(3):162-174. https://doi.org/10.1016/j.currproblcancer.2010.04.003
Suh, John H. ; Videtic, Gregory M M ; Aref, Amr M. ; Germano, Isabelle ; Goldsmith, Brian J. ; Imperato, Joseph P. ; Marcus, Karen J. ; McDermott, Michael W. ; McDonald, Mark W. ; Patchell, Roy A. ; Robins, H. Ian ; Rogers, C. Leland ; Wolfson, Aaron ; Wippold, Franz J. ; Gaspar, Laurie E. / ACR Appropriateness Criteria® : Single Brain Metastasis. In: Current Problems in Cancer. 2010 ; Vol. 34, No. 3. pp. 162-174.
@article{78e06aebb4644cf4b307f22d6a136ba0,
title = "ACR Appropriateness Criteria{\circledR}: Single Brain Metastasis",
abstract = "Single brain metastasis represents a common neurologic complication of cancer. Given the number of treatment options that are available for patients with brain metastasis and the strong opinions that are associated with each option, appropriate treatment for these patients has become controversial. Prognostic factors such as recursive partitioning analysis and graded prognostic assessment can help guide treatment decisions. Surgery, whole brain radiation therapy (WBRT), stereotactic radiosurgery or combination of these treatments can be considered based on a number of factors. Despite Class I evidence suggestive of best therapy, the treatment recommendation is quite varied among physicians as demonstrated by the American College of Radiology's Appropriateness Panel on single brain metastasis. Given the potential concerns of the neurocognitive effects of WBRT, the use of SRS alone or SRS to a resection cavity has gained support. Since aggressive local therapy is beneficial for survival, local control and quality of life, the use of these various treatment modalities needs to be carefully investigated given the growing number of long-term survivors. Enrollment of patients onto clinical trials is important to advance our understanding of brain metastasis.",
author = "Suh, {John H.} and Videtic, {Gregory M M} and Aref, {Amr M.} and Isabelle Germano and Goldsmith, {Brian J.} and Imperato, {Joseph P.} and Marcus, {Karen J.} and McDermott, {Michael W.} and McDonald, {Mark W.} and Patchell, {Roy A.} and Robins, {H. Ian} and Rogers, {C. Leland} and Aaron Wolfson and Wippold, {Franz J.} and Gaspar, {Laurie E.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.currproblcancer.2010.04.003",
language = "English",
volume = "34",
pages = "162--174",
journal = "Current Problems in Cancer",
issn = "0147-0272",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - ACR Appropriateness Criteria®

T2 - Single Brain Metastasis

AU - Suh, John H.

AU - Videtic, Gregory M M

AU - Aref, Amr M.

AU - Germano, Isabelle

AU - Goldsmith, Brian J.

AU - Imperato, Joseph P.

AU - Marcus, Karen J.

AU - McDermott, Michael W.

AU - McDonald, Mark W.

AU - Patchell, Roy A.

AU - Robins, H. Ian

AU - Rogers, C. Leland

AU - Wolfson, Aaron

AU - Wippold, Franz J.

AU - Gaspar, Laurie E.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Single brain metastasis represents a common neurologic complication of cancer. Given the number of treatment options that are available for patients with brain metastasis and the strong opinions that are associated with each option, appropriate treatment for these patients has become controversial. Prognostic factors such as recursive partitioning analysis and graded prognostic assessment can help guide treatment decisions. Surgery, whole brain radiation therapy (WBRT), stereotactic radiosurgery or combination of these treatments can be considered based on a number of factors. Despite Class I evidence suggestive of best therapy, the treatment recommendation is quite varied among physicians as demonstrated by the American College of Radiology's Appropriateness Panel on single brain metastasis. Given the potential concerns of the neurocognitive effects of WBRT, the use of SRS alone or SRS to a resection cavity has gained support. Since aggressive local therapy is beneficial for survival, local control and quality of life, the use of these various treatment modalities needs to be carefully investigated given the growing number of long-term survivors. Enrollment of patients onto clinical trials is important to advance our understanding of brain metastasis.

AB - Single brain metastasis represents a common neurologic complication of cancer. Given the number of treatment options that are available for patients with brain metastasis and the strong opinions that are associated with each option, appropriate treatment for these patients has become controversial. Prognostic factors such as recursive partitioning analysis and graded prognostic assessment can help guide treatment decisions. Surgery, whole brain radiation therapy (WBRT), stereotactic radiosurgery or combination of these treatments can be considered based on a number of factors. Despite Class I evidence suggestive of best therapy, the treatment recommendation is quite varied among physicians as demonstrated by the American College of Radiology's Appropriateness Panel on single brain metastasis. Given the potential concerns of the neurocognitive effects of WBRT, the use of SRS alone or SRS to a resection cavity has gained support. Since aggressive local therapy is beneficial for survival, local control and quality of life, the use of these various treatment modalities needs to be carefully investigated given the growing number of long-term survivors. Enrollment of patients onto clinical trials is important to advance our understanding of brain metastasis.

UR - http://www.scopus.com/inward/record.url?scp=77953095060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953095060&partnerID=8YFLogxK

U2 - 10.1016/j.currproblcancer.2010.04.003

DO - 10.1016/j.currproblcancer.2010.04.003

M3 - Article

C2 - 20541055

AN - SCOPUS:77953095060

VL - 34

SP - 162

EP - 174

JO - Current Problems in Cancer

JF - Current Problems in Cancer

SN - 0147-0272

IS - 3

ER -